Related references
Note: Only part of the references are listed.Osteoporosis in Inflammatory Bowel Disease
Tauseef Ali et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Vitamin D deficiency in patients with active systemic lupus erythematosus
V. Z. C. Borba et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Altered bone metabolism in inflammatory disease: role for nutrition
Kevin D. Cashman
PROCEEDINGS OF THE NUTRITION SOCIETY (2008)
Chronic pediatric inflammatory diseases: Effects on bone
Anuradha Viswanathan et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2008)
Osteoporosis and inflammation
Gregory R. Mundy
NUTRITION REVIEWS (2007)
Improvement of lumbar bone mass after infliximab therapy in Crohn's disease patients
Marina Mauro et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease
Ramsey Sabit et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
How can we prevent multisystem complications of cystic fibrosis?
J. Stuart Elborn
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Inflammation is the main determinant of low bone mineral density in pediatric inflammatory bowel disease
Massimiliano Paganelli et al.
INFLAMMATORY BOWEL DISEASES (2007)
Osteoclasts: What do they do and how do they do it?
Steven L. Teitelbaum
AMERICAN JOURNAL OF PATHOLOGY (2007)
Extra-skeletal effects of bisphosphonates
Addolorata Corrado et al.
JOINT BONE SPINE (2007)
Role of RANKL inhibition in osteoporosis
Michael McClung
ARTHRITIS RESEARCH & THERAPY (2007)
Growth hormone treatment improves growth and clinical status in prepubertal children with cystic fibrosis: Results of a multicenter randomized controlled trial
Dana S. Hardin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Therapy Insight: osteoporosis and osteonecrosis in systemic lupus erythematosus
Nancy E. Lane
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)
Osteoclastogenesis during infective exacerbations in patients with cystic fibrosis
Elizabeth F. Shead et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Intravenous pamidronate in combination with calcium and vitamin D: Highly effective in the treatment of low bone mineral density in inflammatory bowel disease
PCF Stokkers et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2006)
The role of T lymphocytes in bone metabolism
MN Weitzmann et al.
IMMUNOLOGICAL REVIEWS (2005)
Maintenance infliximab treatment is associated with improved bone mineral density in Crohn's disease
M Bernstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Consensus statement: Guide to bone health and disease in cystic fibrosis
RM Aris et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients
VCZ Borba et al.
LUPUS (2005)
Antibody treatments of inflammatory arthritis
MA Brown
CURRENT MEDICINAL CHEMISTRY (2005)
Guidelines for the management of inflammatory bowel disease in adults
MJ Carter et al.
GUT (2004)
Effect of antitumour necrosis factor-α therapy on bone turnover in patients with active Crohn's disease:: a prospective study
BM Ryan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Osteoporosis in systemic lupus erythematosus: factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone density
CA Pineau et al.
LUPUS (2004)
A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease
SA Bartram et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin
AJ Ashcroft et al.
IMMUNITY (2003)
Bone density improves with disease remission in patients with inflammatory bowel disease
DM Reffitt et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2003)
Vitamin K supplementation in cystic fibrosis
JHL van Hoorn et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2003)
Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis
E Romas et al.
BONE (2002)
Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease
KV Haderslev et al.
GASTROENTEROLOGY (2000)
Share Paper
